|
End-of-day quote
Buenos Aires S.E.
2026-09-21
|
5-day change | 1st Jan Change | ||
| 27.60 USD | +0.36% |
|
+0.07% | +17.95% |
| 09-21 | Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations | MT |
| 09-21 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 467B 407B 384B 350B 655B 44,775B 656B 4,596B 1,772B 22,808B 1,756B 1,717B 73,601B | P/E 2026 * |
33.4x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 529B 461B 434B 396B 742B 50,676B 743B 5,202B 2,005B 25,814B 1,987B 1,943B 83,301B | EV / Sales 2026 * |
7.83x | EV / Sales 2027 * | 7.08x |
| Free-Float |
95.71% | Yield 2026 * |
2.59% | Yield 2027 * | 2.73% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| ABBVD | End-of-day quote | |
Buenos Aires S.E.
| ABBV | End-of-day quote |
Last Transcript: AbbVie Inc.
| 1 day | +0.36% | ||
| 1 week | +0.07% | ||
| Current month | +2.00% | ||
| 1 month | -0.36% | ||
| 3 months | +21.16% | ||
| 6 months | +31.43% | ||
| Current year | +17.95% |
| 1 week | 27.13 |  | 27.74 |
| 1 month | 25.84 | | 28.09 |
| Current year | 20.13 | | 28.42 |
| 1 year | 20.13 | | 28.42 |
| 3 years | 13 | | 28.42 |
| 5 years | 10.75 | | 28.42 |
| 10 years | 10.75 | | 28.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Ed Rapp
BRD | Director/Board Member | 69 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +0.07% | - | - | 466B | |
| +1.04% | +2.34% | +54.91% | +111.75% | 1,028B | |
| -0.19% | +1.18% | +52.94% | +66.69% | 651B | |
| +0.20% | +1.04% | +18.88% | +72.38% | 466B | |
| +2.24% | +0.94% | +37.61% | +45.31% | 346B | |
| +0.90% | +1.95% | +18.79% | +25.27% | 266B | |
| +0.48% | +3.34% | +11.11% | +15.38% | 259B | |
| +1.95% | +3.06% | +37.75% | +45.93% | 208B | |
| -7.65% | -7.28% | -33.09% | -59.52% | 191B | |
| +0.30% | +2.83% | +31.97% | +100.03% | 186B | |
| Average | +0.06% | +2.45% | +25.65% | +47.02% | 400.19B | |
| Weighted average by Cap. | +0.54% | +2.23% | +35.56% | +65.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.59B 58.93B 55.5B 50.55B 94.77B 6,475B 94.89B 665B 256B 3,298B 254B 248B 10,644B | 73.49B 64.08B 60.35B 54.96B 103B 7,041B 103B 723B 279B 3,586B 276B 270B 11,573B |
| Net income | 14.08B 12.28B 11.56B 10.53B 19.74B 1,349B 19.77B 138B 53.37B 687B 52.89B 51.71B 2,217B | 19.09B 16.64B 15.67B 14.27B 26.76B 1,829B 26.8B 188B 72.35B 931B 71.7B 70.11B 3,006B |
| Net Debt | 61.59B 53.7B 50.58B 46.06B 86.36B 5,901B 86.47B 606B 233B 3,006B 231B 226B 9,700B | 53.09B 46.29B 43.6B 39.7B 74.44B 5,086B 74.54B 522B 201B 2,591B 199B 195B 8,361B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | US$27.60 | +0.36% | 26 |
| 26-09-18 | US$27.50 | +0.26% | 147 |
| 26-09-17 | US$27.43 | +0.99% | 54 |
| 26-09-16 | US$27.16 | -1.56% | 34 |
| 26-09-15 | US$27.59 | +0.04% | 69 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- ABBVD Stock
Select your edition
All financial news and data tailored to specific country editions
